Taurine 11 pp 875-887 | Cite as

Protective Effect of Taurine on Apoptosis of Spinal Cord Cells in Diabetic Neuropathy Rats

  • Inam-u-llah
  • Xiaoxia Shi
  • Mengren Zhang
  • Kaixin Li
  • Pingan Wu
  • Raheel Suleman
  • Muhammad Shahbaz
  • Ayaz Taj
  • Fengyuan Piao
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1155)


Diabetes mellitus (DM) is a condition characterized by chronic hyperglycemia, which leads to diabetic neuropathy and apoptosis in the spinal cord. Taurine has been found to ameliorate the diabetic neuropathy and control apoptosis in various tissues. However, there are few reports that discuss the direct relationship between spinal cord and anti-apoptotic effect of taurine. In this study, DM was induced in male SD rats with STZ @ 25 mg/Kg of body weight in combination with high fat diet. After 2 weeks, they were divided into four groups as DM: diabetic rats, T1 (0.5%), T2 (1%) and T3 (2%) taurine solution, while control group was non-diabetic rats (no treatment). The results showed that DM increased apoptosis, decreased phosphorylated Akt and Bad. DM decreased expression of Bcl-2 and increased the Bax. Moreover, the release of cytochrome c into cytosol was increased in DM and activation of caspase-3 was also increased. However, taurine reversed all these abnormal changes in a dose dependent manner. Our results suggested the involvement of Akt/Bad signaling pathway and mitochondrial apoptosis pathway in protective effect of taurine against apoptosis in the spinal cord of diabetic rats. Therefore, taurine may be a potential medicine against diabetic neuropathy by controlling apoptosis.


Diabetic neuropathy Spinal cord Apoptosis Taurine Anti-apoptosis 


Conflict of Interest

It is declared that there is no conflict of interest among the authors.

Research Subjects

It is declared that no animal was harmed or hurt except according to ethics.

Informed Consent

It is declared that this manuscript is submitted after consent from all authors and all authors are aware of this submission.


  1. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R et al (2005) Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28(4):956–962CrossRefGoogle Scholar
  2. Cnop M, Welsh N, Jonas J-C, Jörns A, Lenzen S, Eizirik DL (2005) Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(suppl 2):S97–S107CrossRefGoogle Scholar
  3. Danciu TE, Adam RM, Naruse K, Freeman MR, Hauschka PV (2003) Calcium regulates the PI3K-Akt pathway in stretched osteoblasts. FEBS Lett 536(1–3):193–197CrossRefGoogle Scholar
  4. Das J, Sil PC (2012) Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats. Amino Acids 43(4):1509–1523CrossRefGoogle Scholar
  5. Das J, Vasan V, Sil PC (2012) Taurine exerts hypoglycemic effect in alloxan-induced diabetic rats, improves insulin-mediated glucose transport signaling pathway in heart and ameliorates cardiac oxidative stress and apoptosis. Toxicol Appl Pharmacol 258(2):296–308CrossRefGoogle Scholar
  6. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91(2):231–241CrossRefGoogle Scholar
  7. De Luca A, Pierno S, Camerino DC (2015) Taurine: the appeal of a safe amino acid for skeletal muscle disorders. J Transl Med 13(1):243CrossRefGoogle Scholar
  8. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM et al (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275(5300):661–665CrossRefGoogle Scholar
  9. Eaton SE, Harris ND, Rajbhandari SM, Greenwood P, Wilkinson ID, Ward JD et al (2001) Spinal-cord involvement in diabetic peripheral neuropathy. Lancet 358(9275):35–36CrossRefGoogle Scholar
  10. Ford ES, Mokdad AH, Giles WH, Brown DW (2003) The metabolic syndrome and antioxidant concentrations: findings from the third national health and nutrition examination survey. Diabetes 52(9):2346–2352CrossRefGoogle Scholar
  11. Garchon HJ, Luan JJ, Eloy L, Bédossa P, Bach JF (1994) Genetic analysis of immune dysfunction in non-obese diabetic (NOD) mice: mapping of a susceptibility locus close to the Bcl-2 gene correlates with increased resistance of NOD T cells to apoptosis induction. Eur J Immunol 24(2):380–384CrossRefGoogle Scholar
  12. Hanke J (2000) Apoptosis and occurrence of Bcl-2, Bak, Bax, Fas and FasL in the developing and adult rat endocrine pancreas. Anat Embryol 202(4):303–312CrossRefGoogle Scholar
  13. Hawkins CL, Davies MJ (2001) Generation and propagation of radical reactions on proteins. Biochimica et Biophysica Acta (BBA)-Bioenergetics 1504(2–3):196–219CrossRefGoogle Scholar
  14. Hoogwerf BJ, Sferra J, Donley BG (2006) Diabetes mellitus – overview. Foot Ankle Clin 11(4):703–715CrossRefGoogle Scholar
  15. Huxtable RJ (2002) Expanding the circle 1975–1999: sulfur biochemistry and insights on the biological functions of taurins Taurine 4. Springer, New York, pp 1–25Google Scholar
  16. Kamboj SS, Vasishta RK, Sandhir R (2010) N-acetylcysteine inhibits hyperglycemia-induced oxidative stress and apoptosis markers in diabetic neuropathy. J Neurochem 112(1):77–91CrossRefGoogle Scholar
  17. Lelkes E, Unsworth BR, Lelkes PI (2001) Reactive oxygen species, apoptosis and alte1red NGF-induced signaling in PC12 pheochromocytoma cells cultured in elevated glucose: an in vitro cellular model for diabetic neuropathy. Neurotox Res 3(2):189–203CrossRefGoogle Scholar
  18. Li Z-G, Zhang W, Grunberger G, Sima AA (2002) Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res 946(2):221–231CrossRefGoogle Scholar
  19. Lin S, Yang J, Wu G, Liu M, Luan X, Lv Q et al (2010) Preventive effect of taurine on experimental type II diabetic nephropathy. J Biomed Sci 17(1):S46CrossRefGoogle Scholar
  20. Lin S, Yang J, Wu G, Liu M, Lv Q, Yang Q, Hu J (2013) Inhibitory effects of taurine on STZ-induced apoptosis of pancreatic islet cells Taurine 8. Springer, New York, pp 287–297Google Scholar
  21. Lu Y, Lin B, Zhong J (2017) The therapeutic effect of dexmedetomidine on rat diabetic neuropathy pain and the mechanism. Biol Pharm Bull 40(9):1432–1438CrossRefGoogle Scholar
  22. Mandrup-Poulsen T (2003) Apoptotic signal transduction pathways in diabetes. Biochem Pharmacol 66(8):1433–1440CrossRefGoogle Scholar
  23. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9(9):1195CrossRefGoogle Scholar
  24. Oja SS, Saransaari P (2007) Pharmacology of taurine. Paper presented at the Proceedings-Western Pharmacology SocietyGoogle Scholar
  25. Rahmeier FL, Zavalhia LS, Tortorelli LS, Huf F, Géa LP, Meurer RT et al (2016) The effect of taurine and enriched environment on behaviour, memory and hippocampus of diabetic rats. Neurosci Lett 630:84–92CrossRefGoogle Scholar
  26. Rashid K, Das J, Sil PC (2013) Taurine ameliorate alloxan induced oxidative stress and intrinsic apoptotic pathway in the hepatic tissue of diabetic rats. Food Chem Toxicol 51:317–329CrossRefGoogle Scholar
  27. Reagan LP (2012) Diabetes as a chronic metabolic stressor: causes, consequences and clinical complications. Exp Neurol 233(1):68–78CrossRefGoogle Scholar
  28. Reske-Nielsen E, Lundbaek K, Gregersen G, Harmsen A (1970) Pathological changes in the central and peripheral nervous system of young long-term diabeticsModifications pathologiques dans le système nerveux central et périphérique de sujets jeunes, diabétiques depuis longtempsPathologische Veränderungen am zentralen und peripheren Nervensystem von jüngeren Langzeit-Diabetikern. Diabetologia 6(2):98–103CrossRefGoogle Scholar
  29. Revsin Y, Rekers NV, Louwe MC, Saravia FE, De Nicola AF, De Kloet ER, Oitzl MS (2009) Glucocorticoid receptor blockade normalizes hippocampal alterations and cognitive impairment in streptozotocin-induced type 1 diabetes mice. Neuropsychopharmacology 34(3):747CrossRefGoogle Scholar
  30. Russell JW, Golovoy D, Vincent AM, Mahendru P, Olzmann JA, Mentzer A, Feldman EL (2002) High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 16(13):1738–1748CrossRefGoogle Scholar
  31. Selvarajah D, Wilkinson ID, Emery CJ, Harris ND, Shaw PJ, Witte DR et al (2006) Early involvement of the spinal cord in diabetic peripheral neuropathy. Diabetes Care 29(12):2664–2669CrossRefGoogle Scholar
  32. Singh N, Anand S (1994) Cell death by apoptosis. Indian J Exp Biol 32(12):843–847PubMedGoogle Scholar
  33. Steenbergen C, Afshari CA, Petranka JG, Collins J, Martin K, Bennett L et al (2003) Alterations in apoptotic signaling in human idiopathic cardiomyopathic hearts in failure. Am J Phys Heart Circ Phys 284(1):H268–H276Google Scholar
  34. Takatani T, Takahashi K, Uozumi Y, Matsuda T, Ito T, Schaffer SW et al (2004) Taurine prevents the ischemia-induced apoptosis in cultured neonatal rat cardiomyocytes through Akt/caspase-9 pathway. Biochem Biophys Res Commun 316(2):484–489CrossRefGoogle Scholar
  35. Verdile G, Fuller SJ, Martins RN (2015) The role of type 2 diabetes in neurodegeneration. Neurobiol Dis 84:22–38CrossRefGoogle Scholar
  36. Wang Y, Wu Y, Luo K, Liu Y, Zhou M, Yan S et al (2013) The protective effects of selenium on cadmium-induced oxidative stress and apoptosis via mitochondria pathway in mice kidney. Food Chem Toxicol 58:61–67CrossRefGoogle Scholar
  37. Winiarska K, Szymanski K, Gorniak P, Dudziak M, Bryla J (2009) Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits. Biochimie 91(2):261–270CrossRefGoogle Scholar
  38. Xi X, Gao L, Hatala DA, Smith DG, Codispoti MC, Gong B et al (2005) Chronically elevated glucose-induced apoptosis is mediated by inactivation of Akt in cultured Müller cells. Biochem Biophys Res Commun 326(3):548–553CrossRefGoogle Scholar
  39. Yasuda H, Terada M, Maeda K, Kogawa S, Sanada M, Haneda M et al (2003) Diabetic neuropathy and nerve regeneration. Prog Neurobiol 69(4):229–285CrossRefGoogle Scholar
  40. Zhang WJ, Tan YF, Yue J, Vranic M, Wojtowicz J (2008) Impairment of hippocampal neurogenesis in streptozotocin-treated diabetic rats. Acta Neurol Scand 117(3):205–210CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Inam-u-llah
    • 1
  • Xiaoxia Shi
    • 1
  • Mengren Zhang
    • 1
  • Kaixin Li
    • 1
  • Pingan Wu
    • 1
  • Raheel Suleman
    • 2
  • Muhammad Shahbaz
    • 3
  • Ayaz Taj
    • 4
  • Fengyuan Piao
    • 1
  1. 1.Department of Occupational and Environmental HealthDalian Medical UniversityDalianChina
  2. 2.Institute of Food Science and Technology, Chinese Academy of Agricultural ScienceBeijingChina
  3. 3.Department of Food Science and TechnologyMuhammad Nawaz Sharif University of AgricultureMultanPakistan
  4. 4.Department of Biochemistry and Molecular BiologyDalian Medical UniversityDalianChina

Personalised recommendations